Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03)
The summary for the Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03): Scientific cooperation between India and the U.S. has taken place under a variety of bilateral umbrella agreements, including the Indo-U.S. Science and Technology (S&T) Sub-Commission, the Gandhi-Reagan S&T Initiative, the U.S.-India Fund, and the current S&T Cooperation Agreement. Building upon these agreements and initiatives, representatives of the United States and the Government of India signed a Memorandum of Understanding on July, 9 1987 implementing the Indo-U.S. Vaccine Action Program (VAP) in order to expand collaborative vaccine research. The goal of the VAP is to support collaborative vaccine-related research projects that ultimately reduce the burden of infectious diseases of importance in India, the U.S., the South Asian region and globally. Applications are encouraged from organizations/institutions that propose to conduct vaccine-related research through U.S.-Indo collaborations on the following: dengue, influenza (including avian influenza), malaria, enteric diseases, HIV/AIDS, and tuberculosis. Basic, translational, clinical, or epidemiological vaccine research may be proposed.
|Federal Grant Title:||Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03)|
|Federal Agency Name:||National Institutes of Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||PA-13-179|
|Type of Funding:||Grant|
|CFDA Descriptions:||Allergy, Immunology and Transplantation Research|
|Current Application Deadline:||May 07, 2016|
|Original Application Deadline:||May 07, 2016|
|Posted Date:||Apr 03, 2013|
|Creation Date:||Apr 03, 2013|
|Archive Date:||Jun 07, 2016|
|Total Program Funding:|
|Maximum Federal Grant Award:||$50,000|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply unless from an Indian organization collaborating with a PD/PI from a U.S. organization. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
- Grant Announcement Contact
- NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
- Similar Government Grants
- • Accelerating Discovery of Efficacious Pre-erythrocytic Stage Malaria Vaccines (U01 Clinica...
- • Understanding Phage Biology to Support the Development of Bacteriophage Therapy (R21 Clini...
- • Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01 Clinical T...
- • NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)
- • Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R01 C...
- • Center for HIV/AIDS Vaccine Immunology (CHAVI)
- • Genomics of Transplantation Cooperative Research Program
- • Asthma and Allergic Diseases Cooperative Research Centers
- More Grants from the National Institutes of Health
- • Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
- • A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
- • Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
- • HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
- • National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...